Provision of Antioxidant Therapy in Hemodialysis (PATH) Study

Summary

Studies have shown that end stage renal disease (ESRD) patients have higher levels of blood markers which their body makes in response to increased stress and injury. An increase in these markers have been shown to be related to cardiovascular disease and death in ESRD patients. This study will examine whether antioxidant therapy (Vitamin E and alpha lipoic acid) may decrease these markers.

Timeline

Start

2006-04

Primary completion

2010-09

Completion

2010-09

Drugs

Indications